‘How to’ – Stability Studies

Liposomal drug products, which utilize lipid-based carriers to deliver active ingredients, require specific stability testing to ensure their safety, efficacy, and quality throughout their shelf life. These formulations present unique challenges due to their complex structure and susceptibility to degradation. Regulatory authorities, including the US FDA, EMA, and WHO, provide guidelines for conducting stability studies on liposomal drug products. This guide outlines the steps to conduct stability testing for liposomal drug products in compliance with regulatory requirements.
Click to read the full article.

ICH Q6A, “Specifications: Test Procedures and Acceptance Criteria for New Drug Substances and New Drug Products,” provides guidelines for setting specifications that define the quality of a drug substance or product. Applying ICH Q6A principles to stability testing helps ensure that the product remains within its acceptable quality range throughout its shelf life. This guide outlines the steps to apply ICH Q6A for specification setting in stability studies.
Click to read the full article.

Drug products intended for use in extreme conditions, such as high altitude, extreme temperatures, or high humidity, require specialized stability testing to ensure their safety, efficacy, and quality. Regulatory authorities, including the US FDA, EMA, and WHO, provide guidelines for conducting stability studies under these conditions to maintain product integrity. This guide outlines the steps to conduct stability studies for drug products in extreme conditions according to regulatory guidelines.
Click to read the full article.

Nanomedicines, which utilize nanoscale materials to deliver therapeutic agents, pose unique challenges in stability testing due to their complex structures, surface properties, and interactions with biological systems. Regulatory authorities, including the US FDA, EMA, and WHO, have developed guidelines to ensure the safety, efficacy, and quality of nanomedicines. This guide outlines the steps to implement stability testing for nanomedicines in compliance with regulatory requirements.
Click to read the full article.

Combination vaccines, which protect against multiple diseases with a single injection, require rigorous stability testing to ensure their safety, efficacy, and quality. Regulatory authorities, including the WHO and FDA, provide specific guidelines for conducting stability studies on combination vaccines. This guide outlines the steps to conduct stability studies for combination vaccines in compliance with these regulatory requirements.
Click to read the full article.

Solid dispersions, which improve the solubility and bioavailability of poorly water-soluble drugs, require specific stability testing to ensure their safety, efficacy, and quality. These formulations present unique challenges due to the potential for phase separation, crystallization, or degradation of the drug or polymer matrix. Regulatory authorities, including the US FDA, EMA, and WHO, provide guidelines for conducting stability studies on solid dispersions. This guide outlines the steps to implement stability testing for solid dispersions in compliance with regulatory requirements.
Click to read the full article.

Complex parenteral products, such as injectable emulsions, suspensions, and liposomes, require rigorous stability testing to ensure their safety, efficacy, and quality throughout their shelf life. These products present unique challenges due to their complex formulations, susceptibility to degradation, and potential interactions with packaging materials. Regulatory authorities, including the US FDA, EMA, and WHO, provide guidelines for conducting stability studies on complex parenteral products. This guide outlines the steps to conduct stability studies for these products in compliance with regulatory requirements.
Click to read the full article.

Drugs developed under expedited approval pathways, such as the FDA’s Fast Track, Breakthrough Therapy, Accelerated Approval, and Priority Review, require specialized stability testing to ensure their safety, efficacy, and quality while meeting accelerated timelines. This guide outlines the steps to address stability testing for drugs under expedited approval pathways, complying with regulatory guidelines while managing the challenges of accelerated development.
Click to read the full article.

High-volume manufacturing of drug products requires robust stability testing to ensure product quality, safety, and efficacy throughout the production scale-up and lifecycle. Regulatory authorities, including the US FDA, EMA, and WHO, provide guidelines to ensure that stability testing processes meet the necessary standards for large-scale production. This guide outlines the steps to implement stability testing for high-volume manufacturing in compliance with regulatory requirements.
Click to read the full article.

Temperature-cycling products, such as those subjected to fluctuating temperatures during storage or transportation, require specialized stability testing to ensure their safety, efficacy, and quality. Regulatory authorities, including the US FDA, EMA, and WHO, provide guidelines for conducting stability studies under temperature-cycling conditions to maintain product integrity. This guide outlines the steps to conduct stability studies for temperature-cycling products in compliance with regulatory requirements.
Click to read the full article.